Which factor(s) contribute(s) to digoxin toxicity in a 92-year-old patient? (Select all that apply.)

Questions 263

ATI RN

ATI RN Test Bank

Pharmacological Lifespan Treatment Questions

Question 1 of 5

Which factor(s) contribute(s) to digoxin toxicity in a 92-year-old patient? (Select all that apply.)

Correct Answer: B

Rationale: In older adults, impaired renal function can lead to reduced excretion of digoxin, increasing the risk of toxicity. The prolonged half-life of digoxin in older adults also contributes to toxicity. Taking the medication with meals and diminished mental capacity do not directly contribute to digoxin toxicity.

Question 2 of 5

Which of the following treatments would be most appropriate for this patient?

Correct Answer: D

Rationale: In the context of pharmacological lifespan treatment, the most appropriate option for this patient is D) Amphotericin B and flucytosine. Amphotericin B and flucytosine are commonly used in the treatment of systemic fungal infections, such as cryptococcal meningitis. Amphotericin B works by binding to ergosterol in the fungal cell membrane, leading to cell membrane disruption and cell death. Flucytosine interferes with fungal DNA and RNA synthesis, further inhibiting fungal growth. This combination therapy is effective against a broad spectrum of fungal pathogens and is the recommended treatment for severe systemic fungal infections. Option A) Ampicillin and erythromycin are antibiotics commonly used to treat bacterial infections, not fungal infections. Therefore, they would not be effective in this case. Option B) Saguinavir and foscarnet are antiviral medications used to treat HIV infections and herpes simplex virus infections, respectively. These medications are not indicated for the treatment of systemic fungal infections. Option C) Pyrimethamine and sulfadiazine are used in the treatment of parasitic infections such as toxoplasmosis, not fungal infections. Therefore, they would not be the most appropriate choice for this patient. In an educational context, it is crucial for healthcare providers to have a solid understanding of the mechanisms of action and indications for various medications to ensure appropriate treatment selection for patients. Understanding the rationale behind selecting specific pharmacological treatments based on the underlying pathology is essential for providing effective patient care and optimizing treatment outcomes.

Question 3 of 5

Which of the following best explains the primary advantage of liposomal preparations over the regular colloidal suspension of amphotericin B?

Correct Answer: C

Rationale: In the context of pharmacological lifespan treatment, the primary advantage of liposomal preparations over regular colloidal suspension of amphotericin B lies in option C) Decreased systemic toxicity. This is the correct answer because liposomal formulations encapsulate the drug within lipid bilayers, which allows for targeted delivery to the site of infection while minimizing exposure to healthy tissues. This targeted delivery reduces the overall systemic exposure to the drug, thereby decreasing the potential for toxic side effects commonly associated with amphotericin B, such as nephrotoxicity. Option A) Decreased interactions with other drugs is incorrect as the advantage of liposomal preparations primarily lies in their improved safety profile, not in their drug-drug interaction potential. Option B) Increased antifungal activity spectrum is incorrect as this is not a specific advantage of liposomal preparations over regular colloidal suspension but rather a property of the drug itself. Option D) Decreased drug clearance is incorrect because liposomal preparations do not typically affect drug clearance rates but rather improve drug distribution and reduce toxicity. Educationally, understanding the rationale behind choosing liposomal preparations for certain medications highlights the importance of drug delivery systems in optimizing therapeutic outcomes while minimizing adverse effects. This knowledge is crucial for healthcare professionals in selecting the most appropriate treatment options tailored to individual patient needs.

Question 4 of 5

Which medication is commonly used to treat bipolar disorder by stabilizing mood swings?

Correct Answer: A

Rationale: In the treatment of bipolar disorder, the correct medication option is A) Lithium. Lithium is a mood stabilizer that is commonly used to manage the extreme mood swings associated with bipolar disorder. It helps to reduce the frequency and severity of manic episodes, as well as prevent depressive episodes. Carbamazepine (option B) is also a mood stabilizer used in bipolar disorder treatment, but it is more commonly prescribed for managing manic episodes rather than stabilizing mood swings overall. Gabapentin (option C) is primarily used to treat seizures and nerve pain, not bipolar disorder. Divalproex (option D) is an anticonvulsant medication that can also be used as a mood stabilizer in bipolar disorder; however, lithium is typically preferred as a first-line treatment due to its proven efficacy. Educationally, understanding the rationale behind choosing lithium for bipolar disorder treatment is crucial for healthcare providers and students in the field. It is essential to know the specific mechanisms of action of different medications and their intended therapeutic effects to provide effective care for individuals with bipolar disorder. By grasping the nuances of each medication, healthcare professionals can make informed decisions in prescribing the most appropriate treatment for their patients.

Question 5 of 5

A 55-year-old male with chronic hypertension is prescribed losartan. Losartan works by:

Correct Answer: A

Rationale: In pharmacological lifespan treatment, understanding the mechanism of action of medications is crucial for safe and effective patient care. In this case, the correct answer is A) Blocking the action of angiotensin II at its receptor. Losartan belongs to a class of medications known as angiotensin II receptor blockers (ARBs). By blocking the angiotensin II receptor, losartan prevents the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation, decreased blood pressure, and reduced sodium and water retention. Option B) Inhibiting the conversion of angiotensin I to angiotensin II is incorrect because this is the mechanism of action of ACE inhibitors, not ARBs like losartan. Option C) Increasing sodium excretion in the kidneys does not align with the mechanism of losartan; rather, it is a function of diuretics. Option D) Blocking calcium channels in the blood vessels is the mechanism of calcium channel blockers, not ARBs. Educationally, grasping the specific mechanisms of action of different antihypertensive medications is vital for healthcare providers to make informed decisions when prescribing, monitoring, and educating patients. Understanding how losartan works allows for individualized treatment plans, minimizes adverse effects, and optimizes patient outcomes by targeting the underlying pathophysiology of hypertension.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions